As genetic aberrations are rare events, it would be expected that if additional genetics events, in conjunction with expression of MYC, AKT and BCLXL would be required for tumor growth in vivo, then this would result in monoclonal tumors, and conversely, if not, tumors would be polyclonal. Here, BCL2L1 is linked to neoplasm.